On September 25th , EBC held its latest event in the European Parliament, this time building on the Value of Treatment‘s work on Alzheimer’s and The Socioeconomic impact of Alzheimer’s in Europe. This event was an opportunity to further present the EBC Value of Treatment project, particularly the work and findings of the Alzheimer’s Disease working group.
The event was kindly hosted by MEPs Heinz K. Becker (EPP, AT) and Marian Harkin (ALDE, IE), both members of the European Alzheimer’s Alliance. Geoff Meade moderated the session chaired by EBC President, Prof. Monica Di Luca.
Expert speakers and roundtable participants, presented and led a fruitful conversation around the future of Alzheimers’ research, patients and carers as well as the impact the disease has and will have on society.
Dr. Ron Handels and Prof. Philip Scheltens, members of the VoT Alzheimer’s Working Group, presented their work on the potential health-economic impact of treating Alzheimer’s and the patient journey for people living with Alzheimer Disease. Mr. Nis Peter Nissen gave a national insight, speaking on the cost of informal care of Alzheimer Disease in Denmark.
The roundtable brought together key stakeholders in the Alzheimer’s and neurology communities, including leading academic and policy experts on the socioeconomic burden of Alzheimer’s from organisations such as the OECD- and the European Commission.
More can be found here.